摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-aminopropanoate | 1185295-57-1

中文名称
——
中文别名
——
英文名称
[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-aminopropanoate
英文别名
——
[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-aminopropanoate化学式
CAS
1185295-57-1
化学式
C24H37NO3
mdl
——
分子量
387.563
InChiKey
UHFDEMLDIONMFY-VYIMKSKESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    69.4
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    [(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-aminopropanoate盐酸 作用下, 以 乙醚 为溶剂, 以52%的产率得到3β-hydroxy-pregn-4-en-20-one L-alanine ester hydrochloride
    参考文献:
    名称:
    Development and Screening of Water-Soluble Analogues of Progesterone and Allopregnanolone in Models of Brain Injury
    摘要:
    Preclinical and clinical research findings have revealed that the hormone progesterone, when acutely administered, can dramatically reduce cerebral edema, inflammation, tissue necrosis, and programmed cell death following traumatic brain injury (TBI). The poor aqueous solubility of progesterone, however, limits its potential use as a therapeutic. Several chemically novel analogues of progesterone and its natural metabolite allopregnanolone have been synthesized and screened using both in vitro and whole animal models of TBI. The new derivatives demonstrated greatly improved solubility and select compounds have shown equivalent effectiveness to progesterone in reducing cerebral edema after TBI.
    DOI:
    10.1021/jm900712n
  • 作为产物:
    描述:
    [(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoate 在 哌啶 作用下, 以 乙腈 为溶剂, 反应 0.5h, 以73%的产率得到[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-aminopropanoate
    参考文献:
    名称:
    Development and Screening of Water-Soluble Analogues of Progesterone and Allopregnanolone in Models of Brain Injury
    摘要:
    Preclinical and clinical research findings have revealed that the hormone progesterone, when acutely administered, can dramatically reduce cerebral edema, inflammation, tissue necrosis, and programmed cell death following traumatic brain injury (TBI). The poor aqueous solubility of progesterone, however, limits its potential use as a therapeutic. Several chemically novel analogues of progesterone and its natural metabolite allopregnanolone have been synthesized and screened using both in vitro and whole animal models of TBI. The new derivatives demonstrated greatly improved solubility and select compounds have shown equivalent effectiveness to progesterone in reducing cerebral edema after TBI.
    DOI:
    10.1021/jm900712n
点击查看最新优质反应信息

文献信息

  • METHODS OF NEUROPROTECTION USING NEUROPROTECTIVE STEROIDS AND A VITAMIN D
    申请人:Stein Donald G.
    公开号:US20110306579A1
    公开(公告)日:2011-12-15
    Described herein are compositions and methods for treating or preventing nervous system injury. In particular, the methods and compositions relate to the use of at least one neuroprotective steroid, such as progesterone, and vitamin D.
    本文描述了用于治疗或预防神经系统损伤的组合物和方法。具体而言,这些方法和组合物涉及使用至少一种神经保护类固醇,如孕激素,和维生素D。
  • STEROID ANALOGUES FOR NEUROPROTECTION
    申请人:Macnevin Christopher
    公开号:US20110263553A1
    公开(公告)日:2011-10-27
    Provided are steroid analogues functionalized with polar substituents at the C3 and/or C20 positions of the steroid ring system that exhibit improved water solubility. Also provided are pharmaceutical compositions comprising the steroid analogues and methods using the novel steroid analogues for the treatment and prevention of neurodegeneration in a patient following injury to the central nervous system.
    提供的是具有带极性取代基的类固醇类似物,这些取代基位于类固醇环系统的C3和/或C20位置,具有改善的水溶性。还提供了包含这些类固醇类似物的药物组合物,以及使用新型类固醇类似物治疗和预防中枢神经系统损伤后患者的神经退行性疾病的方法。
  • Steroid analogues for neuroprotection
    申请人:Emory University
    公开号:US10716795B2
    公开(公告)日:2020-07-21
    Provided are steroid analogues functionalized with polar substituents at the C3 and/or C20 positions of the steroid ring system that exhibit improved water solubility. Also provided are pharmaceutical compositions comprising the steroid analogues and methods using the novel steroid analogues for the treatment and prevention of neurodegeneration in a patient following injury to the central nervous system.
    本发明提供了在类固醇环系统的 C3 和/或 C20 位上用极性取代基进行官能化的类固醇类似物,这些类固醇类似物具有更好的水溶性。还提供了包含这些类固醇类似物的药物组合物,以及使用这些新型类固醇类似物治疗和预防中枢神经系统损伤后患者神经变性的方法。
  • Conjugated Neuroactive Steroid Compositions And Methods Of Use
    申请人:Marx Christine
    公开号:US20130245253A1
    公开(公告)日:2013-09-19
    The present disclosure provides modified neuroactive steroids. The modified neuroactive steroids may comprise, consist of, or consist essentially of a therapeutic agent and/or a modifying moiety. The modified neuroactive steroid can have modified characteristics as compared to native neuroactive steroids that do not include a modifying moiety and/or therapeutic agent. The modified neuroactive steroid may be, for example, modified pregnenolone, pregnenolone metabolites, allopregnanolone, and/or allopregnanolone metabolites. The modified neuroactive steroids can be used to treat, prevent and/or ameliorating a phenotypic state of interest in a subject.
  • Steroid Analogues for Neuroprotection
    申请人:Emory University
    公开号:US20170065615A1
    公开(公告)日:2017-03-09
    Provided are steroid analogues functionalized with polar substituents at the C3 and/or C20 positions of the steroid ring system that exhibit improved water solubility. Also provided are pharmaceutical compositions comprising the steroid analogues and methods using the novel steroid analogues for the treatment and prevention of neurodegeneration in a patient following injury to the central nervous system.
查看更多